| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 13,213,283 | 21,157,780 | 16,000,667 | | Cost of Revenue | 4,394,302 | 5,763,840 |
-
| | | Gross Profit | 8,818,982 | 15,393,940 | 16,000,667 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,545,182 | 4,452,440 | 2,892,362 | | Non Recurring | 2,399,894 | 366,560 | 137,351 | | Others | 235,102 | 2,147,220 | 2,971,038 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,638,804 | 8,427,720 | 9,999,917 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 61,620 | (198,692) | | Earnings Before Interest And Taxes | 3,583,330 | 8,562,020 | 9,785,223 | | Interest Expense | 3,592,576 | 5,507,880 | 7,174,230 | | Income Before Tax | (9,246) | 3,054,140 | 2,610,993 | | Income Tax Expense | (54,153) | 361,820 | 477,393 | | Minority Interest |
-
|
-
| (1,334) | | | | Net Income From Continuing Ops | 44,907 | 2,692,320 | 2,206,943 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 44,907 | 2,692,320 | 2,206,943 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $44,907 | $2,692,320 | $2,206,943 |
|
0.50% Nasdaq 
0.05 (0.55%) 
Income Statement
